Engineering of catalytic bioscavengers of organophosphorus compounds;Ingénierie d'enzymes pour la protection, la décontamination et le traitement des agressions par les composés organophosphorés

Bulletin de l'Academie Nationale de Medecine

Volumn 191, Issue 1, 2007, Pages 93-112

  Masson, Patrick ^a   Nachon, Florian ^a   Rochu, Daniel ^a  

^a Centre de Recherches du Service de Santé des Armées   (France)

Author keywords

Decontamination; Engineering; Enzymes; Organophosphorus compounds

Indexed keywords

ANTIDOTE; CHOLINESTERASE REACTIVATOR; ORGANOPHOSPHORUS COMPOUND; PHOSPHOTRIESTERASE;

HUMAN; INTOXICATION; REVIEW;

ANTIDOTES; CHOLINESTERASE REACTIVATORS; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHORIC TRIESTER HYDROLASES; POISONING;

EID: 34548645465     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. COSTA L.C. -Current issues in organophosphate toxicity. Clin. Chim. Acta, 2006, 366, 1-13.
2. BAILLEV., CLARKE P.G.H., BROCHIER G., DORANDEU F., VERNA J-M., FOUR E., LALLEMENT G, CARPENTIER P. -Soman-induced convulsions : the neuropathology revisited. Toxicology, 2005, 215, 1-24.
3. EDDELSTON M., EYER P., WOREK F., MOHAMED F., SENARATHNA L., VON MEYER L., JUSZCZAK E., HITTARAGE A., AZHAR S., DISSANAYAKE W., SHERIFF M.H.R., SZINICZ L., DAWSON A.H, BUCKLEY N.A. -Differences between organophosphorus insecticides in human selfpoisoning : a prospective cohort study. Lancet, 2005, 336, 1452-1459.
4. AAS P. -Future considerations for the medical management of nerve-agent intoxication. Prehosp. Disasl. Med, 2003, 18, 208-216.
5. WETHERELL J., PRICE M., MUNFORD H., ARMSTRONG S., SCOTT L. -Development of next generation medical countermeasures to nerve agent poisoning. Toxicology, 2007, 233, 120-127.
6. WILLEMS J.L., DE BISSCHOP H.C. -Cholinesterase reactivation in organophosphorus poisoned patients depends on the plasma concentrations of the oxime pralidoxime methylsulphate and the organophosphate. Arch. Toxicol, 1993, 67, 79-84.
7. KALISTE-KORHONEN E., TUOVINEN K., HÉNINEN O. -Interspecies differences in enzymes reacting with organophosphates and their inhibition by paraoxon in vitro. Hum. Exp. Toxicol., 1996, 15, 972-978.
8. SHIN D.M., Gu L., XIA Y.R., NA VAN M., LI W.F., HAMA S., CASTELLANI L. W., FURLONG C.E., COSTA L.G., FOGELMAN A.M., Lusis A.J. -Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature, 1998, 394, 284-287.
9. SOGORB M.A., DIAZ-ALEJO N., ESCUDERO M.A., VILANOVA E. -Phosphotriesterase activity identified in purified serum albumins. Arch. Toxicol, 1998, 72, 219-226.
10. DÉSIRÉ B., SAINT-ANDRÉ S. -Interaction of soman with ß-cyclodextrine. Fundam. Appl Toxicol, 1986, 7, 646-657.
11. GLIKSON M., ARAD-YELLIN R., GHOZI M., RAVEH L., GREEN B.S., ESHHAR Z. -Characterization of soman-binding antibodies raised against soman analogs. Mol. Immunol, 1992, 29, 903-910.
12. YOKOYAMA K., OGURA Y., KISHIMOTO M., HINOSHITA F., HARA S., YAMADA A., MIMURA N., SEKI A., SAKAI O. -Blood purification for severe sarin poisoning after the Tokyo subway attack. J. Am. Med. Assoc, 1995, 274, 379.
13. REDINBO M.R., POTTER P.M. -Mammalian carboxylesterases : from drug targets to protein therapeutics. Drug Discov. Today, 2005, 10, 313-325.
14. DOCTOR B.P, SAXENA A. -Bioscavengers for the protection of humans against organophosphate toxicity. Chem.-Biol. Interact., 2005, 157-158, 167-171.
15. ASHANI Y, PISTINNER S. -Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphayes toxicity : a mathematically based toxicokinetic model. Toxicol. Sci., 2004, 77, 358-367.
16. nd edition, CRC Press, Boca Raton, 2007, sous presse.
17. ASHANI Y., LEADER H., ROTHSCHILD N., DOSORETZ C. -Combined effect of organophosphorus hydrolase and oxime on the reactivation rate of diethylphosphoryl-acetylcholinesterase conjugates. Biochem. Pharmacol, 1998, 55, 159-168.
18. LEJEUNE K.E., RUSSELL A.J. -Biocatalytic nerve agent detoxification in fire fighting foams. Biotechnol Bioengn., 1999, 62, 659-665.
19. GILL I., BALLESTEROS A. -Degradation of organophosphorus nerve agents by enzymepolymer nanocomposite : efficient biocatalytic materials for personal protection and large-scale detoxification. Biotechnol Bioengn., 2000, 70, 400-410.
20. CHEN W., MULCHANDANI A. The use of biocatalysts for pesticide detoxification. TIBTECH, 1998, 16, 71-76.
21. AMITAL H., TUR-KASPAL I., TASHMA Z., HENDLER I., SHOENFELD Y. -Catalytic antibodies : generation, nature, and possible role as chemical warfare scavengers. Milit. Med., 1996, 161, 7-10.
22. MASURIER N., ESTOUR F., FROMENT M.T., LEFÉVRE B., DEBOUZY J.C., BRASME B., MASSON P., LAFONT O. -Synthesis of 2-substituted ß-cyclodextrin derivatives with a hydrolytic activity against the organophosphorylester paraoxon. Eur. J. Med. Chem., 2005, 40, 615-623.
23. MERONE L., MANDRICH L., ROSSI M., MANCO G. -A thermostable phosphotriesterase from the archaeon Sulfolobus solfataricus : cloning, overexpression and properties. Extremophiles, 2005, 9, 297-305.
24. POLHUIJS LANGENBERG J.P., BENSCHOP H.P. -New method for retrospective detection of exposure to organophosphorus anticholinesterases : Application to alleged sarin victims of Japanese terrorists. Toxicol. Appl Pharmacol, 1997, 146, 156-161.
25. MASSON P., JOSSE D., LOCKRIDGE O., VIGUIÉ N., TAUPIN C., BUHLER C. -Enzymes hydrolyzing organophosphates as potential catalytic scavengers against organophosphate poisoning. J. Physiol, 1998, 92, 357-362.
26. COHEN O., KRONMAN C., RAVEH L., MAZOR O., ORDENTLICH A, SHAFFERMAN A. -Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds. Mol. Pharmacol.,2006, 70, 1121-1131.
27. CHTILARU T., KRONMAN C., ZEEVI M., KAM A., HAREL A., ORDENTLICH A., VELAN B., SHAFFERMAN A. -Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels. Biochem J., 1998, 336, 647-658.
28. KLEIN M.D., LANGER R. -Immobilized enzymes in medicine : an emerging approach to new drug therapies. TIBTECH, 1986, 4, 179-185.
29. COWAN J., SINTON C.M., VARLEY A.W., WIANS F.H., HALEY R.W., MUNFORD R.S. -Gene therapy to prevent organophosphate intoxication. Toxicol. Appl. Pharmacol, 2001, 173, 1-6.
30. Fu A.L., WANG Y.X., SUN M.J. -Naked DNA prevents soman intoxication. Biochem. Biophys. Res. Communie, 2005, 328, 901-905.
31. Li B., DUYSEN E.G., POLUEKTOVA L.Y., MURRIN L.C., LOCKRIDGE O. -Protection from the toxicity of diisopropylfluorophosphate by adeno-associated virus expressing acetylcholinesterase. Toxicol. Appl. Pharmacol, 2006, 214, 152-165.
32. GORDON R.C., DOCTOR B.P., SAXENA A., FEASTER S.R., MAXWELL D., ROSS, M., LENZ D., LEIEUNE K., RUSSELL A. -Preparation of enzymatically active sponges or foams for detoxification of hazardous compounds. U.S. Patent n° US 6, 642, 037 B2, Nov. 4, 2003.
33. BRAUE E.H., HOBSON S.T., GOVARDHAN C., KHALAF N. -Active topical skin protectants containing OPAA and CLECS. CiS. Patent n° US 6, 410, 604 Bl, Jun. 25, 2002.
34. Rapports de l'ONU : a) Report of the specialists appointed by the Secretary-General to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons (S/16433 du 26 mars 1984) b) Reports of the mission dispatched by the Secretary-General to investigate allegations of the use of chemicals weapons in the conflict between Iran and Iraq (S/17911 du 12 mars 1986 et S/18852 du 8 mai 1987).
35. JÄARV J. -Insight into the putative mechanism of esterase acting simultaneously on carboxyl and phosphoryl compounds. In : Enzymes hydrolysing organophosphorus compounds. Reiner, E., Aldridge, W.N. and Hoskin, FCG, Eds., Ellis Horwood Ltd, Chichester, UK, pp. 221-225, 1989.
36. SUSSMAN J.L., HAREL M., FROLOW F., OEFNER C., GOLDMAN A., TOKER L., SILMAN I.-Atomic structure of acetylcholinesterase from Torpedo californica : a prototypic acetylcholine-binding protein. Science, 1991, 253, 872-879.
37. MILLARD C.B., LOCKRIDGE O., BROOMFIELD C.A. -Design and expression of organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase. Biochemistry, 1995, 34, 15925-15933.
38. LOCKRIDGE O., BLONG R.M., MASSON P., MILLARD C.B., BROOMFIELD C.A. -A single amino acid substitution Gly 117His, confers phosphotriesterase activity on human butyrylcholinesterase. Biochemistry, 1997, 36, 786-795.
39. SHAFFERMAN A., ORDENTLICH A., BARAK D., STEIN D., ARIEL N., VELAN B. -Aging of phosphylated human acetylcholinesterase : catalytic processes mediated by aromatic and polar residues of the active centre. Biochem. J., 1996, 318, 833-840.
40. VIRAGH C., AKHMETSHIN R., KOVACH I. -Unique push-pull mechanism of dealkylation of soman-inhibited cholinesterases. Biochemistry, 1997, 36, 8243-8252.
41. MASSON P. CLERY C., GUERRA P., REDSLOB A., ALBARET C., FORTHIER P-L. -Hydration change during the aging of phosphorylated human bytyrylcholinesterase : importance of residues D70 and E197 in the water network as probed by hydrostatic and osmotic pressures. Biochem. J., 1999, 343, 361-369.
42. MILLARD C.B., LOCKRIDGE O., BROOMFIELD C.A. -Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase : synergy results in a somanase. Biochemistry, 1999, 37, 237-247.
43. NEWCOMB R.D., CAMPBELL P.M., OLLIS D.L., CHEAH E., RUSSELL R.J., OAKESHOTT J.G. -A single amino acid substitution converts a carboxylesterase to an organophosphorus hydrolase and confers insecticide resistance on a blowfly. Proc Natl. Acad. Sci., USA 1997, 94, 7464-7468.
44. SCHOPFER L.M., TICU-BOECK A., BROOMFIELD C.A., LOCKRIDGE O. -Mutants of human butyrylcholinesterase with organophosphate hydrolase activity; evidence that His117 is a general base catalyst for hydrolysis of echothiophate. J. Med. Chem. Def, 2004, 2, 1-21.
45. POYOTT., NACHON F., FROMENT M.T., LOIODICEM., WIESELERS., SCHOPFER L.M., LOCKRIDGE O., MASSON P. -Mutant of Bungarusfasciatus acetylcholinesterase with low affinity and low hydrolase activity toward organophosphorus esters. Biochim. Biophys. Acta, 2006, 1764, 1470-1478.
46. NICOLET Y., LOCKRIDGE O., MASSON P., FONTECILLA-CAMPS J.C, NACHON F. -Crystal structure of human butyrylcholinesterase and its complexes with substates and products. J. Biol. Chem., 2003, 278, 41141-41147.
47. PAN Y., GAO D. YANG W., CHO H., YANG G., TAI HH., ZHAN CG. -Computational redesign of human butyrylcholinesterase for anticocaine medication, Proc. Natl Acad, USA, 2005, 102, 16656-16661.
48. KOVARIK Z., RADIC Z., BERMAN H.A., TAYLOR P. -Mutation of acetylcholinesterase to enhance oxime-assisted catalytic turnover of methylphosphonates. Toxicology, 2007, 233, 79-84.
49. DOUCHET J.C., MASSON P., MORELIS P. -Elimination de la Cholinesterase plasmatique humaine purifiée injectée au rat. Trav. Sci. Serv. Santé Armées, 1982, 5, 342-347.
50. KRONMAN C., VELAN B., MARCUS D., ORDENTLICH A., REUVENY S., SHAFFERMAN A.Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation. Biochem. J., 1995, 311, 959-967.
51. SAXENA A., ASHANI Y., RAVEH L., STEVENSON D., PATEL T., DOCTOR B.P. -Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases. Mol. Pharmacol, 1998, 55, 112-122.
52. KRONMAN C., CHILTLARU T., ELHANANY E., VELAN B., SHAFFERMAN A. -Hierarchy of Post-translational Modifications Involved in the Circulatory Longevity of Glycoproteins. J. Biol Chem., 2000, 275, 29488-29502.
53. BENNING M.M., Kuo, J.M., RAUSHEL F.M., HOLDEN H.M. -Three-dimensional structure of phosphotriesterase : an enzyme capable of detoxifying organophosphate nerve agents. Biochemistry, 1994, 55, 15001-15007.
54. HILL C.M., LI W.S., THODEN J.B., HOLDEN H.M., RAUSHEL F.M. -Enhanced degradation of chemical warfare agents through molecular engineering of the phosphotriesterase active site. J. Am. Chem. Soc., 2003, 125, 8990-8991.
55. GHANEM E., RAUSHEL F.M. -Detoxification of organophosphate nerve agents by bacterial phosphotriesterase. Toxicol Appl. Pharmacol., 2005, 207, 459-470.
56. PETRIKOVICS I., PAPAHADJOPOULOS D.I., HONG K., CHENG T.C, BASKIN S.I., JIANG J., JASZBERENYi J.C, LOGUE B.A., SZILASI M., MCGUINN W.D., WAY J.L. -Comparing therapeutic and prophylactic protection against the lethal effect of paraoxon. Toxicol. Sci., 2004, 77, 258-262.
57. SMOLEN A., ECKERSON H.W., GAN K.N., HAILAT N., LA DU, B.N. -Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase. Drug Metab. Dispos., 1991, 19, 107-112.
58. WATSON A.D., BERLINER J.A., HAMA S.Y., LA DU, B.N. -Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin. Invest., 1995, 96, 2882-2891.
59. KHERSONSKY O., TAWFIK D.S. -Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase. Biochemistry, 2005, 44, 6371-6382.
60. JOSSE D., XIE W., RENAULT F., ROCHU D., SCHOPFER L.M., MASSON P., LOCKRIDGE O.Identification of residues essential for human paraoxonase (PONl) arylesterase/ organophosphatase activity. Biochemistry, 1999, 38, 2816-2825.
61. FOKINE A., MORALES R., CONTRERAS-MARTEL C., CARPENTIER P., RENAULT F., ROCHU D., CHABRIÉRE E. -Direct phasing at low resolution of a protein co-purified with human paraoxonase (PONl). Acta Cryst., 2003, D 59, 2083-2087.
62. YEUNG D.T., JOSSE D., NICHOLSON J.D., KHANAL A., MCANDREW C.W., BAHNSON B.J., LENZ D.E., CERASOLI D.M. -Structure/function analyses of human serum paraoxonase (HuPON1) mutants designed from a DFPase-like homology model, Biochim. Biophys. Acta, 2004, 1702, 67-77.
63. HAREL M., AHARONI A., GAIDUKOV L., BRUMSHTEIN B., KHERSONSKY O., MEGED R., DVIR H., RAVELLI R.B.G., MCCARTY A., TOKER L., SILMAN I., SUSSMAN J. -Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat. Struct. Mo! Biol, 2004, 11, 412-419.
64. KATSEMI V., LÜCKE C, KOEPKE J., LÖHR F., MAURER S., FRITZSCH G., RÜTERJANS H.Mutational and structural studies of the diisopropylfluorophosphatase from Loligo vulgaris shed new light on the catalytic mechanism of the enzyme. Biochemistry 2005, 44, 9022-9033.
65. BLUM M.-M., LÖHR F., RICHARDT A., RÜTERJANS H., CHEN J.C-H -H. Binding of a designed substrate analogue to diisopropyl fluorophosphatase : Implications for the phosphotriesterase mechanism. J. Am. Chem. Soc, 2006, 128, 12750-12757.
66. LA DU B.N. -Structural and functional diversity of paraoxonases. Nature Med., 1996, 2, 1186-1187.
67. ROCHU D., CHABRIÉRE E., MASSON P. -Human paraoxonase : a promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology, 2007, 233, 47-59.
68. AMITAI G., GAIDUKOV L., ADANI R., YISHAY S., YACOV G., KUSHNIR M., TEOTLBOIM S., LINDENBAUM M., BEL P., KHERSONSKY O., TAWFIK D.S., MESHULAM H. -Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase. FEBS J., 2006, 273, 1906-1919.
69. JAMES R.W., DEAKIN S.P. -The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Rad. Biol. Med., 2004, 37, 1986-1994.
70. GAIDUKOV L., TAWFIK D.S. -High affinity, stability, and lactonase activity of serum paraoxonase PONl anchored on HDL with apoA-I. Biochemistry, 2005, 44, 11843-11854.
71. MORALES R., BERNNA A., CARPENTIER P., CONTRERAS-MARTEL C., RENAULT F., NICODEME M., CHESNE-SECK M.-L. BERNIER F., SCHAEFFER C., DIEMER H., VAN-DORSSELAER A., FONTECILLACAMPS J.C, MASSON P., ROCHU D. CHABRIÉRE E. -Serendipitous discovery and X-ray structure of a human phosphate binding apolipoprotein. Structure, 2006, 14, 601-609.
72. RENAULT F., CHABRIÉRE E., ANDRIEU J.P., DUBLET B., MASSON P., ROCHU D. -Tandem purification of two HDL-associated partner proteins in human plasma, paraoxonase (PONl) and phosphate binding protein (HPBP) using hydroxyapatite chromatography. J. Chromatogr. B, 2006, 556, 15-21.
73. BRADSHAW G., GUTTIERREZ A., MIYAKE J.H., DAVIS K.R., Li A.C., GLASS C.K., CURTISS L.K., DAVIS R.A. -Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice. Proc. Natl. Acad. Sci., USA 2005, 102, 11029-11034.
74. CHENG T-C., DEFRANK J.J., RASTOGI V.K. Alteromonas prolidase for organophosphorus G-agent decontamination. Chem. Biol. Interact., 1999, 119-120, 455-462.
75. RUSSEL A.J., BERBERICH J.A., DREVON G.F., KOEPSEL R.R. -Biomaterials for mediation of chemical and biological warfare agents. Annu. Rev. Biomed. Engn., 2003, 5, 1-27.
76. MATURANO M.D., BONGIBAULT V., WILLSON M., KLAÉBÉ A., FOURNIER D. -A chemical model for the enzymatic mono de-alkylation of (methyl and ethyl) parathion by glutathione-Stransferase. Tetrahedron, 1997, 53, 17241-17246.
77. FOURNIER D., BRIDE J-M., POIRIÉ M., BERGE J-B., PLAPP F.W. -Insect glutathione S-transferases. J. Biol. Chem., 1992, 267, 1840-1845.
78. CASIDA J.E, QUISTAD G.B. -Organophosphate toxicity : safety aspects of nonacetylcholinesterase secondary targets. Chem. Res. Toxicol., 2004, 17, 983-998.
79. SMOLEN A., ECKRESON H.W., GAN K.N., HAILAT N., LA DU B.N. -Characteristics of the genetically determined polymorphic forms of human serum paraoxonase/arylesterase. Drug. Metab. Dispos., 1991, 19, 107-112.
80. DAVIS H.G., RICHTER R.J., KEIFER M., BROOMFIELD C.A., SOWALLA J., FURLONG CE. -The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nature Genet., 1996, 14, 334-336.
81. HARTLIEB J., RÜTERJANS H. -Insights into the reaction mechanism of the diisopropylfluorophosphatase from Loligo vulgaris by means of kinetic studies, chemical modification and site-directed mutagenesis. Biochim. Biophys. Acta, 2001, 1546, 312-324.
82. Kuo J.N., CHAE M.Y., RAUSHEL F.M. -Perturbation of the active site of phosphotriesterase. Biochemistry, 1997, 36, 1982-1988.
83. LAI K., STOLOWICH N.J., WILD J.R. -Characterization of P-S bond hydrolysis in organophosphorothioate pesticides by organophosphorus hydrolase. Arch. Biochem. Biophys., 1995, 318, 59-64.
84. DUMAS D.P., DURST H.D., LANDIS W.G., RAUSHEL F.W. -Inactivation of organophosphorus nerve agents by the phosphotriesterase from Pseudomonas diminuta. Arch. Biochem., Biophys. 1990, 277, 155-159.
85. RASTOGI V.K., DEFRANCK J.J., CHENG T.-C., WILD J.R. -Enzymatic hydrolysis of russian-VX by organophosphorus hydrolase. Biochem. Biophys. Res. Comm., 1997, 247, 294-296.